Translational Research in Maternal and Pediatric Pharmacology and Therapeutics
Forecasted Federal grant Posted
- Opportunity number
- PAR-28-059
- Agency
-
National Institutes of Health
Department of Health and Human Services
- Applications expected due
- Award size
- Not on record
Opportunity facts
- Expected posting
- Assistance listings
- Funding instrument
- Grant
- Category
-
- Health
- Eligible applicants
-
- Tribal Organizations (Not Federally Recognized)
- Higher Education Inst. (Public)
- Public or Indian Housing Auth.
- Higher Education Inst. (Private)
- Other
- For Profit Organizations
- Independent School Districts
- 501(c)(3) Nonprofits
- Non-501(c)(3) Nonprofits
- Special District Governments
- Tribal Governments (Federally Recognized)
- Small Businesses
- County Governments
- State Governments
- City/Township Governments
- Points of contact
Opportunity details come from Grants.gov. Updated .
About this opportunity
The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) is forecasting a Notice of Funding Opportunity to solicit applications for translational and clinical research in maternal and pediatric pharmacology and therapeutics, with no application submission date currently set. This forecast supports Congressionally-mandated activities under the Best Pharmaceuticals for Children Act and recommendations of the Task Force on Research Specific to Pregnant Women and Lactating Women.
Eligible applicants include higher education institutions (public and private), state and local governments, tribal governments (federally recognized and non-federally recognized), small businesses, for-profit organizations, 501(c)(3) and non-501(c)(3) nonprofits, public or Indian housing authorities, independent school districts, faith-based and community-based organizations, regional organizations, eligible federal agencies, U.S. territories or possessions, and non-domestic entities.
The research program targets four complementary objectives: advancing precision medicine through novel tools, models, and technologies; discovering and developing novel therapeutics or enhancing existing drugs for improved safety and efficacy; enhancing patient-provider communication about drug effectiveness and safety risks; and optimizing dissemination, implementation, sustainment, and scale-up of evidence-based interventions. The overall goal is to improve safe and effective precision therapeutics during pregnancy, lactation, and across childhood.
Awards flow through CFDA 93.865 (Child Health and Human Development Extramural Research). The program receives dual scientific review by non-NIH scientists, with evaluation based on significance, approach, innovation, investigator qualifications, and environment. Recent awards in the program range from $39 thousand to $794 million, with research project grants typically spanning $300 thousand to over $700 thousand.
Forecast synopsis
The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), as part of its stewardship of Congressionally-mandated activities under the Best Pharmaceuticals for Children Act (BPCA) and implementation of recommendations of the Task Force on Research Specific to Pregnant Women and Lactating Women (PRGLAC), intends to renew and publish a Notice of Funding Opportunity (NOFO) to solicit applications to promote translational and clinical research in pregnant women, lactating women, infants, children, and adolescents to: (1) advance precision medicine through the development, testing, and implementation of novel tools, models, and other technologies; (2) discover and develop novel therapeutics or enhance the usage of existing drugs for safer and more effective medications; (3) enhance patient-provider communications about drug effectiveness and safety risks; and, (4) optimize the dissemination, implementation, sustainment, and scale-up of evidence-based interventions to these patient populations. The overall goal is to improve safe and effective precision therapeutics during pregnancy, lactation, and across childhood. Applications are not being solicited at this time.
Eligibility
Other Eligible ApplicantsIndian/Native American Tribal Governments (Other than Federally Recognized);Eligible Agencies of the Federal Government;U.S. Territory or Possession;Faith-based or Community-based Organizations;Regional Organizations;Non-domestic (non-U.S.) Entities (Foreign Institutions).
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar grant opportunities
- Ask GovTribe AI about this opportunity